Mastodon

Doktor MOM® Inhaler (Pencil) Instructions for Use

Marketing Authorization Holder

Unique Pharmaceutical Laboratories (India)

Company Division

J. B. Chemicals & Pharmaceuticals, Ltd. (India)

ATC Code

R05X (Other remedies for the treatment of colds)

Active Substances

Methyl salicylate (Ph.Eur.)

Camphor (Ph.Eur.)

Levomenthol (Rec.INN)

Dosage Form

Bottle OTC Icon Doktor MOM® Inkhayler Inhalation pencil 202.7 mg+202.7 mg+61.35 mg: case 1 pc.

Dosage Form, Packaging, and Composition

Inhalation pencil cylindrical, perforated at the base and equipped with an inhalation hole in the upper part, a case with a screw cap; containing a cylindrical tampon made of fibrous acetate viscose, impregnated with a mixture of medicinal substances with a specific odor and wrapped in waxed paper.

1 pencil
Levomenthol 207.7 mg
Camphor 207.7 mg
Methyl salicylate 61.35 ml

Excipients : liquid paraffin.

1 pc. – plastic cases (1) – cardboard packs.

Clinical-Pharmacological Group

A drug with counterirritant action, used to facilitate nasal breathing during acute respiratory infections

Pharmacotherapeutic Group

Local irritant

Pharmacological Action

A combined drug, the action of which is determined by the composition of its components.

Camphor has antiseptic, local irritant, local analgesic, and anti-inflammatory action.

Levomenthol has local irritant, analgesic, counterirritant, antipruritic, and antiseptic action. The antiseptic activity is manifested by non-selective damage to microbial cells. The irritating (counterirritant) effect helps to reduce pain sensations. The local action is accompanied by vasoconstriction, a sensation of cold, turning into a sensation of slight burning and tingling.

Methyl salicylate has anti-inflammatory and analgesic action. It normalizes increased capillary permeability, improves microcirculation, and reduces swelling and infiltration of inflamed tissues.

Indications

Symptomatic therapy of inflammatory diseases of the respiratory tract (rhinitis, pharyngitis, laryngitis, tracheitis) to facilitate nasal breathing in the treatment of acute respiratory diseases accompanied by rhinitis, a feeling of nasal congestion.

ICD codes

ICD-10 code Indication
J00 Acute nasopharyngitis (common cold)
J02 Acute pharyngitis
J03 Acute tonsillitis
J04 Acute laryngitis and tracheitis
J06.9 Acute upper respiratory infection, unspecified
ICD-11 code Indication
CA00 Acute nasopharyngitis
CA02.Z Acute pharyngitis, unspecified
CA03.Z Acute tonsillitis, unspecified
CA05 Acute laryngitis or tracheitis
CA07.0 Acute upper respiratory tract infection of unspecified site

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer topically by nasal inhalation only.

For children aged 6 to 11 years, administer 1 inhalation into each nostril.

For adults and children over 12 years, administer 2 inhalations into each nostril.

Repeat the dosing regimen every 2 hours as needed for symptom relief.

Do not exceed the recommended dosage for the respective age group.

Limit the duration of use to a maximum of 3 consecutive days.

Discontinue use if symptoms persist or worsen after 3 days of treatment.

Avoid contact of the pencil tip with the nasal mucosa to prevent contamination.

Ensure the inhalation hole is clear before each use.

Replace the cap securely after each application to maintain product integrity.

Use the inhalation pencil only for the intended individual; sharing may spread infection.

Adverse Reactions

Possible allergic reactions, contact eczema, bronchospasm, the appearance of a burning sensation, sneezing, or increased nasal congestion.

Contraindications

  • Bronchial asthma,
  • Bronchospasm;
  • Whooping cough;
  • Children under 6 years of age;
  • Pregnancy;
  • Lactation period;
  • Hypersensitivity to the components of the drug.

Use in Pregnancy and Lactation

Contraindicated.

Pediatric Use

Contraindicated in children under 6 years of age.

Special Precautions

The recommended doses should not be exceeded.

One pencil should not be used by more than one person. This may lead to the spread of infection.

Do not use for more than 3 days. Frequent and prolonged use of the drug may lead to increased nasal congestion.

Overdose

No cases of drug overdose have been reported to date.

Drug Interactions

There are no data on the interaction of the drug with other medicinal products.

Storage Conditions

Store in places inaccessible to children at a temperature not exceeding 25°C (77°F).

Shelf Life

The shelf life is 3 years.

Do not use after the expiration date printed on the packaging.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS